Measuring, understanding and responding to drug problems in Europe
Expert meeting: 23-27 September 2013, Lisbon
EMCDDA week “Measuring, understanding and responding to drug problems in Europe”
The first EMCDDA week on ‘Measuring, understanding and responding to drug problems in Europe’ from 23-27 September 2013 gathered around 100 experts from across the European Union as well as the Russian Federation, South Africa, the United States and countries of the Western Balkans. The week brought together under the same ‘roof’ experts from diverse areas of work to inspire cross-disciplinary analyses of the drugs problem and responses to it and included policy and intervention components.
This week has brought together EMCDDA’s technical work in a number of different fields, namely:
- measuring drug problems through the Problem Drug Use indicator (now focusing on “High risk drug use”),
- understanding drug problems and treatment uptake through the Treatment Demand indicator,
- and monitoring of Health and Social Responses to drug problems.
Disclaimer: The EMCDDA is not responsible for the content of the presentations; the responsibility lies with the authors.
For further use of content of the presentations: If you wish to make use of any parts of a presentation, please contact the author directly (the e-mail and contact details are in the ‘List of participants’).
- Meeting agenda
- Meeting minutes
- Draft guidelines treatment prevalence 2013 ver 3.0
- TDI - Progress on treatment Demand indicator
- TDI - Injection trends in Europe and outside Europe
- Gregorio Barrio & Ana Sarasa, Spain: Injection trends: preliminary results of TDI data analysis
- Kamran Niaz, UNODC: Global trends in drug injection
- Konstantin Vyshinsky, Russia: Injection trends in Russia
- Maria Fé Caces, US: Injection trends in US
- Siphokazi Dada, South Africa: Injection trends in South Africa
- TDI - Outcome from last EMCDDA projects related to TDI
- Andrew Jones, United Kingdom: Previous treatment field and database matching - Report from the UK
- Linda Montanari, EMCDDA: TDI Treatment Prevalence Project
- Dagmar Hedrich & Alessandro Pirona, EMCDDA: Presentation of EMCDDA coverage estimates, using POU estimates as a denominator
- Bruno Guarita, EMCDDA: The “Other Drugs” in the TDI: what and how many they are?
- TDI - Parallel Sessions
- Session 1
- Summary
- Jerome Antoine: Polydrug use among TDI clients in Belgium
- Bruno Genetti: Polydrug use in Italian drug clients
- Marta Struzik: Polydrug use among Polish drug clients
- Martta Forsell: Polydrug use of treatment clients in Finland
- Sofia Lopes Costa: Polydrug use treatment clients in Luxembourg
- Marcis Trapencieris: Polydrug use and trends in Latvian methamphetamine clients
- Session 2
- Session 3
- Session 4
- Summary
- Tanja Bastianic: Cannabis trends among TDI clients in France
- Noelia Llorens: Cannabis trends in Spain
- Christine Marchand Agius: Cannabis trends in Malta
- Suzi Lyons: Cannabis trends in Ireland
- Marta Struzik: Cannabis trends among Polish drug clients
- Anna Peterfi: Cannabis trends among TDI clients in Hungary
- Session 5
- Session 1
- Joint Session TDI-PDU
- Jeroen Wisselink, The Netherlands: Treatment demand data on crack cocaine users
- Maarten Cruyff, The Netherlands: Estimating the Prevalence of Crack Dependence Using Capture-Recapture with Institutional and Field Data: A Three-City Study in the Netherlands
- Charlotte Davies, United Kingdom: In and out of treatment
- Gordon Hay & Jonathan Knight, United Kingdom: Prevalence, treatment coverage and needs assessment
- Vlastimil Necas & Bruno Sopko, Czech Republic: Relationship between TDI and PDU data in the Czech Republic - what can we learn from it
- Marcis Trapencieris, Latvia: Users in treatment (TDI) and users in a Riga cohort study of high risk drug users
- PDU - Introduction and developmental work
- Danica Thanki, EMCDDA: State of the key indicator Problem Drug Use, brief overview of the meeting
- Eleni Kalamara, EMCDDA: Breakdowns by age and gender – short presentation of data and plans
- Katerina Skarupova, Czech Republic: Informing PDU revision: Report on Progress
- Gregorio Barrio & Ana Sarasa, Spain: Injecting drug use – trends in Europe (analysis of TDI data)
- PDU - Methodological session
- Maarten Cruyff, The Netherlands: One-Source Capture-Recapture:Models, applications and software
- Carla Rossi, Italy: One sample capture-recapture with covariates: explanation of the technique and recent study example
- Gregorio Barrio, Spain: IDU estimate based on adaptation of HIV multiplier
- Ellen Amundsen, Norway: Revision of IDU estimates carried out by mortality multiplier method – taking into account different groups of users
- Martin Steppan, Germany: Probabilistic Multiple Recapture – a new methodology. First results and technical details for internationally comparable results
- PDU - Estimates of treatment coverage
- PDU - Trends analysis
- Ellen Amundsen, Norway: How to interpret PDU data in terms of trends
- Gordon Hay, United Kingdom: Trend analysis in the UK
- Martin Busch, Austria: Austria – insight into trends using multi-indicator analysis
- Martin Steppan, Germany: Minimal assumption relative incidence estimation – a new methodology
- Sigrid Vorobjov, Estonia: Trends based on cross-sectional studies of injecting drug users (IDUs) in Estonia: 2005-2012
- PDU - Injection of new drugs. User populations, patterns of use

Belgium
Bulgaria



























